Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase Releases Results

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Apr 29, 2022 10:31pm

169 Views

Post# 34644296

RE:RE:RE:Theralase Releases Results

Agreed. A small fraction of shares will dance back and forth.

However, one catalyst might be if more patient data gets reported as some interim update. If that is reasonable that would nudge it up. The soonest we would get another patient update....I'm guessing, is late summer. That assumes they continue with that model. They seemed to have stopped the quarterly newsletter labelled as such.

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute